Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary Patou currently holds 15,542 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary Patou has been a net seller of PCRX stock. They have purchased $35.9K and sold $11.9M worth of shares.
Gary Patou's most recent insider trade was on Nov 22, 2024, when they sold 3,086 shares at $0.00 per share.
Gary Patou serves as Executive at Pacira Pharmaceuticals, Inc. (PCRX). They have executed 84 insider transactions totaling $11.9M over their tenure at the company.
Gary Patou holds the position of Executive at Pacira Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gary Patou has shown a selling trading pattern, with $35.9K in total purchases and $11.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gary Patou was on Jul 14, 2014, when they sold $2.4M worth of PCRX shares. This transaction involved 27,593 shares at $86.91 per share.
Gary Patou currently owns 15,542 shares of Pacira Pharmaceuticals, Inc. (PCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary Patou's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary Patou has 84 Form 4 filings on record as an insider at Pacira Pharmaceuticals, Inc..
Set alerts for Gary Patou and 40,000+ other insiders.